Injunction denied: Pharma argument fails to freeze Nevada drug pricing law

Fierce Pharma ------- Drug pricing regulation hasn't gained much ground on a national level, but in Nevada, there's a fierce fight over pricing and transparency for diabetes medications. In the latest twist, the industry lost its bid to stall a new law that's designed to shine light on pricing practices. Industry groups PhRMA and BIO filed for a temporary restraining order and preliminary injunction against officials in Nevada, contending that the state's Senate Bill 539 will "impose irreparable injury" against drugmakers. To learn more click on the picture below to read the article.